Dystonia Drugs Market Is Expected to Reach $1378.67 Million by 2031: Says AMR
March 08, 2023 20:30 ET
|
Allied Market Research
Portland, OR, March 08, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global dystonia drugs market was valued at $806.67 million in 2021, and is projected...
ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits
February 01, 2023 08:30 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
December 05, 2022 08:30 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Pacemakers Market to Gain $10.9 Bn Revenue With 8.1% CAGR by 2027 | The Insight Partners
November 15, 2022 08:16 ET
|
The Insight Partners
New York, Nov. 15, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new market research study titled ‘Pacemakers Market Size, Share, Growth, Global Analysis and Forecasts by Product Type,...
RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition
August 08, 2022 08:00 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Global Functional Electrical Stimulation Market to Grow with a CAGR of ~8.5% During 2022-2031; Market to Grow on Account of the Increasing Prevalence of Paralysis and Technological Advancement in the Healthcare Sector
June 22, 2022 08:23 ET
|
Research Nester
New York, June 22, 2022 (GLOBE NEWSWIRE) -- As Per World Health Organization, every year, between 250000 to 500000 persons suffer a spinal cord injury in the world. Functional electrical stimulation...
Ferrer Brings ALSton the Dragon to Life to Raise Awareness of ALS
June 21, 2022 04:00 ET
|
Ferrer
BARCELONA, Spain, June 21, 2022 (GLOBE NEWSWIRE) -- On Global Amyotrophic Lateral Sclerosis / Motor Neuron Disease (ALS/MND) Awareness Day on June 21, the Phantasticals campaign, run by Ferrer, the...
Enteral Feeding Devices Market worth USD 5.37 billion in 2028 with a CAGR of 6.38 %
June 15, 2022 10:53 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 15, 2022 (GLOBE NEWSWIRE) -- In 2020, the enteral feeding devices market accounted for up to USD 3.27 billion. It is predicted to expedite at a CAGR of 6.38% to USD...
IBN (InvestorBrandNetwork) Coverage Initiated for Silo Pharma Inc.
March 30, 2022 08:30 ET
|
Silo Pharma Inc.
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with...
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases
December 20, 2021 07:00 ET
|
ARMGO
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma...